PIM1 and prostate carcinoma: Furthermore, some researches has identified PLK1 as a gene whose depletion was particularly detrimental to the viability of PIM1-overexpressing prostate cancer, which was particularly sensitive to PLK1 inhibition and suggests that PIM1 might be used as a marker for identifying patients who will benefit from PLK1 inhibitor treatment35.